Free Trial

Beam Therapeutics (BEAM) SEC Filings & 10K Form

Beam Therapeutics logo
$29.01 +2.16 (+8.04%)
(As of 12/20/2024 05:31 PM ET)

Recent Beam Therapeutics SEC Filings

DateFilerForm TypeView
12/19/2024
3:10 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
6:01 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
6:06 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2024
6:18 AM
Beam Therapeutics (Issuer)
Guindo Chirfi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/04/2024
6:22 AM
Beam Therapeutics (Issuer)
Guindo Chirfi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
6:08 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:10 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
8:56 AM
Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SC 13G/A
11/05/2024
8:00 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
8:06 AM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
7:30 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:05 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
10:50 AM
Beam Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
3:44 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
10:37 AM
Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/07/2024
4:00 PM
Beam Therapeutics (Subject)
Burrell Terry-Ann (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
4:51 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:52 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:49 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:51 PM
Beam Therapeutics (Subject)
Evans John M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:15 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2024
6:08 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
6:01 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
3:14 PM
Beam Therapeutics (Subject)
Evans John M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
3:30 PM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
3:42 PM
Beam Therapeutics (Issuer)
Fishman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:42 PM
Beam Therapeutics (Issuer)
Walsh Kathleen E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:45 PM
Beam Therapeutics (Issuer)
COOPER GRAHAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:47 PM
Beam Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:47 PM
Beam Therapeutics (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:48 PM
Beam Therapeutics (Issuer)
Shaw Christi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
6:09 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
6:19 AM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/19/2024
3:25 PM
Beam Therapeutics (Filer)
Form ARS
04/19/2024
3:15 PM
Beam Therapeutics (Filer)
Form DEF 14A
04/19/2024
3:20 PM
Beam Therapeutics (Filer)
Form DEFA14A
04/04/2024
7:56 PM
Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
7:57 PM
Beam Therapeutics (Subject)
Burrell Terry-Ann (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
7:57 PM
Beam Therapeutics (Subject)
Evans John M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
7:55 PM
Beam Therapeutics (Subject)
Simon Amy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
7:56 PM
Beam Therapeutics (Subject)
Bellon Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol
04/03/2024
6:39 PM
Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
6:40 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
6:43 PM
Beam Therapeutics (Issuer)
Simon Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
6:33 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
6:36 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:22 PM
Beam Therapeutics (Subject)
Simon Amy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2024
3:10 PM
Beam Therapeutics (Issuer)
Simon Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:10 PM
Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
5:13 PM
Beam Therapeutics (Subject)
Evans John M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
6:40 AM
Beam Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
6:22 AM
Beam Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2024
5:43 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
1:34 PM
Beam Therapeutics (Issuer)
FMR LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:18 PM
ARCH Venture Fund IX, L.P. (Filed by)
Beam Therapeutics (Subject)
Form SC 13G/A
02/12/2024
2:38 PM
Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SC 13G/A
02/09/2024
7:35 AM
Beam Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/06/2024
6:27 AM
Beam Therapeutics (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G/A
01/31/2024
3:47 PM
Beam Therapeutics (Subject)
Evans John M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2024
3:00 PM
ARK Investment Management LLC (Filed by)
Beam Therapeutics (Subject)
Form SC 13G/A
01/25/2024
3:59 PM
Beam Therapeutics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/24/2024
7:42 AM
Beam Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/08/2024
5:55 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:30 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
9:56 AM
Beam Therapeutics (Issuer)
FMR LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BEAM) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners